Certified by Founder Lodge
Johnson & Johnson
United States - New Brunswick, NJ
INVESTOR
1 Disclosed Funding Rounds $25,000,000
52 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Profound Change Requires Boldness.
Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have
| Company | Date | Round | Raised |
|---|---|---|---|
 ArteraAI |
March, 27 ,2023 | Unknown | $90,000,000 |
 Causaly |
July, 14 ,2023 | Series B | $60,000,000 |
 Health In Her HUE |
January, 09 ,2024 | Unknown | $3,000,000 |
 MedCrypt |
November, 02 ,2022 | Series B | $25,000,000 |
 Solenic Medical |
June, 21 ,2023 | Series A | $5,100,000 |
 Arialys Therapeutics, Inc. |
September, 13 ,2023 | Seed | $58,000,000 |
 FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
 Moon Surgical |
June, 30 ,2022 | Series A | $31,300,000 |
| Causaly |
July, 14 ,2023 | Series B | $60,000,000 |
 SwipeRx |
May, 23 ,2022 | Series B | $27,000,000 |
 Tempo Therapeutics |
March, 21 ,2024 | Series A | $12,000,000 |
 Osteal Therapeutics |
September, 26 ,2023 | Series C | $23,000,000 |
 Rapport Therapeutics |
March, 08 ,2023 | Series A | $100,000,000 |
| Arialys Therapeutics, Inc. |
September, 13 ,2023 | Seed | $58,000,000 |
 RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
 HistoSonics, Inc. |
August, 16 ,2024 | Series D | $102,000,000 |
| ArteraAI |
March, 27 ,2023 | Unknown | $90,000,000 |
| Osteal Therapeutics |
September, 26 ,2023 | Series C | $23,000,000 |
| Health In Her HUE |
January, 09 ,2024 | Unknown | $3,000,000 |
 SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| Solenic Medical |
June, 21 ,2023 | Series A | $5,100,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
 ONL Therapeutics |
September, 17 ,2024 | Series D | $65,000,000 |
| Causaly |
July, 14 ,2023 | Series B | $60,000,000 |
| Health In Her HUE |
January, 09 ,2024 | Unknown | $3,000,000 |
| Tempo Therapeutics |
March, 21 ,2024 | Series A | $12,000,000 |
 TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Arialys Therapeutics, Inc. |
September, 13 ,2023 | Seed | $58,000,000 |
| FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
| HistoSonics, Inc. |
August, 16 ,2024 | Series D | $102,000,000 |
| Tempo Therapeutics |
March, 21 ,2024 | Series A | $12,000,000 |
| Osteal Therapeutics |
September, 26 ,2023 | Series C | $23,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| HistoSonics, Inc. |
August, 16 ,2024 | Series D | $102,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| RefleXion Medical |
November, 17 ,2023 | Unknown | $105,000,000 |
| ONL Therapeutics |
September, 17 ,2024 | Series D | $65,000,000 |
| ONL Therapeutics |
September, 17 ,2024 | Series D | $65,000,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Health In Her HUE |
January, 09 ,2024 | Unknown | $3,000,000 |
 Alessa Therapeutics, Inc. |
December, 13 ,2024 | Seed | $15,000,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
 Perceive Biotherapeutics, Inc. |
February, 20 ,2025 | Series A | $15,000,000 |
| FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
| Tempo Therapeutics |
March, 21 ,2024 | Series A | $12,000,000 |
| HistoSonics, Inc. |
August, 16 ,2024 | Series D | $102,000,000 |
| SpectraWAVE, Inc. |
September, 12 ,2024 | Series B | $50,000,000 |
| ONL Therapeutics |
September, 17 ,2024 | Series D | $65,000,000 |
| TRexBio |
November, 14 ,2024 | Series B | $84,000,000 |
| Alessa Therapeutics, Inc. |
December, 13 ,2024 | Seed | $15,000,000 |
| Perceive Biotherapeutics, Inc. |
February, 20 ,2025 | Series A | $15,000,000 |
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
